Skip to main content Skip to main navigation menu Skip to site footer

Karakteristik resipien vaksin CoronaVac di Rumah Sakit Universitas Udayana

Abstract

Background: COVID-19 is an outbreak that the World Health Organization (WHO) declared a global pandemic in 2020. COVID-19 is a disease caused by the pathogen SARS-CoV-2. The method used to cease the spread of COVID-19 is vaccination, including the CoronaVac vaccine. Each recipient of the CoronaVac vaccine certainly has distinct characteristics. This research aims to investigate the characteristics of the CoronaVac vaccine recipient at Udayana University Hospital.

Method: A cross-sectional approach was applied in this research with a total of 140 samples that fulfilled the inclusion requirements taken from medical record data from Udayana University Hospital from March to August 2021.

Result: The results of this research revealed that the recipients’ ages ranged from 19-59 years (87.9%) with male recipients as the majority (51.4%) and being dominated by recipients who worked as civil servants (23.6%). Most of the recipients were from Denpasar City (58.6%). The most prevalent comorbidity experienced by the recipients was hypertension (9.3%). The most common side effect felt after receiving the first dose of vaccine was joint or muscle pain (22.14%), while after receiving the second dose was fever (20%).

Conclusion: The characteristics of the CoronaVac vaccine recipients were dominated by male adult recipients, from Denpasar City and worked as civil servants. The most prevalent comorbidity experienced by the recipients were hypertension. The side effect felt by the recipients after the CoronaVac vaccination were joint or muscle pain, fever and pain, and swelling in the area around the injection.

 

Metode: Penelitian ini menggunakan metode pendekatan cross-sectional dengan total sampel yang memenuhi kriteria inklusi sebanyak 140 sampel yang diambil dari data rekam medis Rumah Sakit Universitas Udayana pada bulan Maret sampai dengan Agustus 2021.

Hasil: Berdasarkan hasil penelitian, didapatkan usia resipien berada pada rentang 19-59 tahun (87,9%) dengan resipien terbanyak adalah berjenis kelamin laki-laki (51,4%) serta didominasi oleh resipien yang bekerja sebagai PNS (23,6%). Kebanyakan resipien berasal dari Kota Denpasar (58,6%). Komorbid yang paling banyak dimiliki oleh resipien adalah hipertensi (9,3%). Efek samping paling banyak yang dirasakan setelah mendapatkan vaksin dosis pertama adalah nyeri sendi atau otot (22,14%), sedangkan setelah pemberian dosis kedua adalah demam (20%).

Kesimpulan: Karakteristik resipien vaksin CoronaVac di Rumah Sakit Universitas Udayana didominasi oleh individu kategori dewasa dengan jenis kelamin laki-laki. Domisili terbanyak resipien vaksin berasal dari Kota Denpasar serta profesi terbanyak yang dimiliki resipien adalah bekerja sebagai PNS. Komorbid paling banyak yang diderita resipien adalah hipertensi. Efek samping yang dialami resipien setelah mendapatkan vaksin CoronaVac adalah nyeri sendi atau otot, demam serta nyeri dan bengkak di area sekitar suntikan.

References

  1. Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Heal. 2020;25(3):278–80.
  2. Li Y Der, Chi WY, Su JH, Ferrall L, Hung CF, Wu TC. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020;27(1):1–23.
  3. Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;226(9):1593–607.
  4. Setiadi W, Rozi IE, Safari D, Daningrat WOD, Johar E, Yohan B, et al. Prevalence and epidemiological characteristics of COVID-19 after one year of pandemic in Jakarta and neighbouring areas, Indonesia: A single center study. PLoS One. 2022;17(5 May):1–9. Available from: http://dx.doi.org/10.1371/journal.pone.0268241
  5. Aswin IG, Sasmana P, Halim W, Komang N, Amanda A, Jaya S, et al. Knowledge Level of COVID-19 Prevention in Banjar Gambang Communities , Seraya Village , Karangasem , Indonesia. 2023;10(2):61–8.
  6. Wang J, Peng Y, Xu H, Cui Z, Williams RO. The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation. AAPS PharmSciTech. 2020;21(6).
  7. Flores-alanis A, Saldaña-ahuactzi Z, Parra-ortega I, Pablo L, Salazar-garc M, Alem YP, et al. Mexican Children and Adolescents. 2022;2019(January 2020):1–15.
  8. Chohan HK, Jamal A, Mubeen M, Khan MU, Junaid M, Chohan MK, et al. The Common Systemic and Local Adverse Effects of the Sinovac COVID-19 Vaccine: An Observational Study From Pakistan. Cureus. 2023;2(5):1–9.
  9. Masyita Dewi L, Irfan Hidayatullah M, Gestia Septiana F. Vaksinasi COVID-19 Massal Bersama POLRES Surakarta dan Fakultas Kedokteran Universitas Muhammadiyah Surakarta di Gedung Graha Saba Buana, Surakarta. J Pengabdi Masy Indones. 2022;2(3):299–304.
  10. Buso G, Agabiti-rosei C, Lorenza M. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information . 2020;(January):2020–3.
  11. Pemerintah Republik Indonesia. Keputusan Direktur Jenderal Pencegahan dan Pengendalian Penyakit Nomor HK.02.02/4/1/2021 tentang Petunjuk Teknis Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19). Kementeri Kesehat RI. 2021;4247608(021):114.
  12. Samuel SM, Varghese E, Triggle CR, Büsselberg D. COVID-19 Vaccines and Hyperglycemia—Is There a Need for Postvaccination Surveillance? Vaccines. 2022;10(3):1–9.
  13. Sasmana IGAP, Wiranata S, Yogananda KC, Wihandani DM, Supadmanaba IGP. Clinicopathological and Prognostic Significance of SRY-Box Transcription Factor 2 ( SOX2 ) Overexpression in Central Nervous System Tumor : A Meta-Analysis. Bali Med J. 2023;12(2):1733–9.
  14. Riad A, Sağıroğlu D, Üstün B, Pokorná A, Klugarová J, Attia S, et al. Article prevalence and risk factors of coronavac side effects: An independent cross-sectional study among healthcare workers in turkey. J Clin Med. 2021;10(12):1–13.
  15. Abbas S, Abbas B, Amir S, Wajahat M. Evaluation of adverse effects with covid-19 vaccination in pakistan. Pakistan J Med Sci. 2021;37(7):1–6.
  16. Pangarsa EA, Setiawan B, Santosa, Naibaho RM, Rizky D, Suyono, et al. Covid-19 vaccination in patients with cancer: Position paper from the indonesian society of hematology and medical oncology (ishmo) of semarang. Bali Med J. 2021;10(1):142–50.
  17. Prabawa IMY, Silakarma D, Susantio S. Effect of prone positioning for improving oxygenation in awake non-intubated COVID-19 patient: a systematic review. Intisari Sains Medis. 2021;12(3):835–41.
  18. Zhafirah nahdah shofi, Palupi LM. Jurnal Media Keperawatan: Politeknik Kesehatan Makassar. J Media Keperawatan Politek Kesehat Makassar. 2019;10(2):85–91.
  19. Amaro C, Monteiro C, Duarte AP. COVID-19 Vaccines Adverse Reactions Reported to the Pharmacovigilance Unit of Beira Interior in Portugal. J Clin Med. 2022;11(19).
  20. Zhao L, Wang J, Li G, Qiu F, Chen C, Zhao M, et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. Psychiatry Res. 2020;14(4)(January):293.
  21. Castaldo M, Waliszewska-Prosół M, Koutsokera M, Robotti M, Straburzyński M, Apostolakopoulou L, et al. Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis. J Headache Pain. 2022;23(1):1–16.
  22. Garrido-Suárez BB, Garrido-Valdes M, Garrido G. Reactogenic sleepiness after COVID-19 vaccination. A hypothesis involving orexinergic system linked to inflammatory signals. Sleep Med. 2022;98(January):79–86.
  23. Syenina A, Gan ES, Toh JZN, de Alwis R, Lin LZ, Tham CYL, et al. Adverse effects following anti–COVID-19 vaccination with mRNA-based BNT162b2 are alleviated by altering the route of administration and correlate with baseline enrichment of T and NK cell genes. PLoS Biol. 2022;20(5):1–23.

How to Cite

Sari, K. R. A. ., Purnamasidhi, C. A. W. ., Kumbara, C. I. Y. K., & Suastika, N. K. W. . (2024). Karakteristik resipien vaksin CoronaVac di Rumah Sakit Universitas Udayana. Medicina, 55(1), 15–19. https://doi.org/10.15562/medicina.v55i1.1282

HTML
73

Total
28

Share

Search Panel

Kadek Ratna Amelia Sari
Google Scholar
Pubmed
Medicina Journal


Cokorda Agung Wahyu Purnamasidhi
Google Scholar
Pubmed
Medicina Journal


Cokorde Istri Yuliandari Krisnawardani Kumbara
Google Scholar
Pubmed
Medicina Journal


Ngakan Ketut Wira Suastika
Google Scholar
Pubmed
Medicina Journal